Medicinal Chemistry International

DRUG PATENTS INTERNATIONAL

MILVEXIAN

https://newdrugapprovals.org/2020/10/24/milvexian/

DRUG PATENTS INTERNATIONAL

Cetuximab Sarotalocan Sodium (Genetical Recombination)

Cetuximab Sarotalocan Sodium is an antibody-drug-conjugate (molecular weight: 156,000-158,000) consisting of tetrasodium salt of Sarotalocan (6-({[3-({(OC-6-13)-bis({3-[bis(3-sulfopropyl)(3-sulfonatopropyl)azaniumyl]propyl}dimethylsilanolato-κO,κO')[(phtalocyaninato(2-)κN29,κN30,κN31,κN32)-1-yl]silicon}oxy)propoxy]carbonyl}amino)hexanoyl (C70H96N11O24S6Si3; molecular weight: 1,752.22)) attached to an average of 2-3 Lys residues of Cetuximab.

[2166339-33-7 , Cetuximab sarotalocan]

https://newdrugapprovals.org/2020/10/12/cetuximab-sarotalocan-sodium/

DRUG PATENTS INTERNATIONAL

Bulevirtide acetate

SEE

https://newdrugapprovals.org/2020/09/26/bulevirtide-acetate/

////////////2020 APPROVALS, ブレビルチド酢酸塩, BULEVIRTIDE ACETATE, EU 2020, MYR GMBH, ORPHAN DESIGNATION, PEPTIDE

DRUG PATENTS INTERNATIONAL

MDSFSANQEI RYSEVTPYHV TSVWTKGVTP PANFTQGEDV FHAPYVANQG WYDITKTFNG

KDDLLCGAAT AGNMLHWWFD QNKDQIKRYL EEHPEKQKIN FNGEQMFDVK EAIDTKNHQL
DSKLFEYFKE KAFPYLSTKH LGVFPDHVID MFINGYRLSL TNHGPTPVKE GSKDPRGGIF
DAVFTRGDQS KLLTSRHDFK EKNLKEISDL IKKELTEGKA LGLSHTYANV RINHVINLWG
ADFDSNGNLK AIYVTDSDSN ASIGMKKYFV GVNSAGKVAI SAKEIKEDNI GAQVLGLFTL
STGQDSWNQT N

Imlifidase

イムリフィダーゼ;

READ AT

https://newdrugapprovals.org/2020/09/22/imlifidase/